Table 3.
Association between sex and VAS at each time point.
| Control Group | Nefopam Group | p-Value | ||||
|---|---|---|---|---|---|---|
| Male (n = 37) | Female (n = 53) | Male (n = 43) | Female (n = 47) | Male | Female | |
| T0 | 2.03 ±0.76 | 1.92 ± 0.83 | 2.07 ± 0.67 | 1.98 ± 0.92 | 0.987 | 0.720 |
| T1 | 3.32 ± 3.44 | 3.40 ± 3.12 | 2.72 ± 2.61 | 3.79 ± 2.99 | 0.740 | 0.582 |
| T2 | 2.57 ± 2.43 | 2.77 ± 2.12 | 2.60 ± 2.18 | 3.30 ± 2.54 | 0.729 | 0.373 |
| T3 | 3.68 ± 2.14 | 3.55 ± 2.20 | 2.86 ± 1.75 | 3.60 ± 1.90 | 0.068 | 0.837 |
| T4 | 3.03 ± 1.66 | 3.03 ± 1.13 | 2.53 ± 1.32 | 2.89 ± 1.26 | 0.099 | 0.651 |
| T5 | 2.27 ± 1.02 | 2.49 ± 1.10 | 2.21 ± 1.19 | 2.34 ± 0.93 | 0.616 | 0.629 |
T0: before surgery, T1: immediately after surgery, T2: after surgery 30 min; T3: after surgery 12 h; T4: after surgery 24 h; and T5: after surgery 48 h.